GPX 002
Alternative Names: Diabetes gene therapy - Genprex; GPX-002Latest Information Update: 13 Jan 2026
At a glance
- Originator University of Pittsburgh
- Developer Genprex
- Class Antihyperglycaemics; Gene therapies
- Mechanism of Action Gene transference; Maf transcription factor replacements; Pancreatic and duodenal homeobox 1 protein replacements
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Preclinical Type 1 diabetes mellitus; Type 2 diabetes mellitus